NCC wins Danish biotech campus contract

WCN Editorial Team 18 Oct 2016 EUROPE BUILDINGS

Swedish construction firm NCC has won a SEK865M ($98M) contract from pharmaceutical firm Novozymes to build the Novozymes Innovation Campus in Copenhagen, Denmark.

The project — to be located in the Lyngby-Taarbæk Municipality — will include the construction of four buildings, to have between two and three stories and to be connected with corridors to promote trans-disciplinary collaboration.

The new 40,200sq m campus will also feature research facilities and a 10,000sq m parking garage.

Palle Bjerre Rasmussen, head of NCC Building in Denmark, said: “At NCC, we are very pleased to play a part in realizing Novozymes’ vision through the construction of a new and exciting innovation campus. The physical environment is crucial to provide people with opportunities to develop creatively.”

Vilhelm Lauritsen will act as the project architect, while GHB as the landscape architect and Ramböll as the lead adviser.

Construction on the project is set to begin at the end of October 2016 and is scheduled for completion at the end of 2018.

* For more information on the Denmark construction market, visit the Construction Intelligence Center Report Store.

With 11 websites and newsletters covering all the key areas within the construction industry, World Construction Industry Network is the leading global construction information resource. READ ABOUT US



World Construction Network | is a product of GlobalData. Copyright © 2022 GlobalData. All rights reserved.